Abstract
The prevalence of antimicrobial co-resistance among ESBL-producing Enterobactereaceae is extremely high in Israel. Multidrug-resistant Proteus mirabilis strains (MDR-PM), resistant to almost all antibiotic classes have been described. The aim was to determine the risk factors for bloodstream infections caused by MDR-PM and clinical outcomes. A retrospective case-control study. Adult patients with PM bacteremia during 7 years were identified retrospectively and their files reviewed for demographics, underlying diseases, Charlson Comorbidity Index, treatment and outcome. One hundred and eighty patients with PM-bloodstream infection (BSI) were included; 90 cases with MDR-PM and 90 controls with sensitive PM (S-PM). Compared to controls, cases more frequently were from nursing homes, had recurrent hospital admissions in the past year and received antibiotic therapy in the previous 3 months, were bedridden and suffered from peripheral vascular disease and peptic ulcer disease (p < 0.001). Two-thirds of the MDR-PM isolates were ESBL-producers vs 4.4% of S-PM isolates (p < 0.001, OR = 47.6, 95% CI = 15.9-142.6). In-hospital crude mortality rate of patients with MDR-PM BSI was 37.7% vs 23.3% in those with S-PM BSI (p = 0.0359, OR = 2, ...Continue Reading
References
Oct 1, 1971·Annals of Internal Medicine·J L AdlerM Finland
Oct 12, 2000·Clinical Microbiology Reviews·C M O'HaraJ M Miller
Oct 15, 2003·The Journal of Infection·Enno Stürenburg, Dietrich Mack
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·Andrea EndimianiAntonio Toniolo
Sep 13, 2007·The Journal of Antimicrobial Chemotherapy·Mitchell J Schwaber, Yehuda Carmeli
Jul 18, 2008·Journal of Clinical Microbiology·R TibbettsW Dunne
Dec 10, 2009·Infection·K Cohen-NahumA Borer
Apr 27, 2010·Journal of Clinical Pathology·C Follmer
May 14, 2010·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Kivanc SerefhanogluHande Arslan
Jun 23, 2011·The Journal of Antimicrobial Chemotherapy·D P WebsterI C J W Bowler
Jan 3, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y MatsumuraS Ichiyama
Jan 31, 2012·European Journal of Internal Medicine·Prashant NasaAkhilesh Singh
Mar 28, 2012·Antimicrobial Agents and Chemotherapy·Mario TumbarelloTeresa Spanu
May 11, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chi-Yu ChenChun-Yu Lin
Oct 9, 2012·BMC Infectious Diseases·Galo PeraltaUNKNOWN SEMI- BLEE STUDY GROUP
Feb 2, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoko KuriharaYasushi Kawakami
Citations
May 22, 2016·Infectious Diseases·Kenneth ChanHusam El-Mugamar
Apr 18, 2018·Therapeutic Advances in Infectious Disease·Nursel Calik Basaran, Sibel Ascioglu
Apr 23, 2019·PLoS Pathogens·Chelsie E ArmbrusterHarry L T Mobley
Oct 16, 2019·Infection and Immunity·Brian S LearmanChelsie E Armbruster
Oct 11, 2017·Pharmacognosy Reviews·Matthew J CheesmanIan E Cock
Jan 18, 2017·The Journal of Antimicrobial Chemotherapy·Felix LangeMartin Kaase
Jun 15, 2017·PLoS Pathogens·Chelsie E ArmbrusterHarry L T Mobley
May 5, 2017·BMC Infectious Diseases·Jin Young AhnJune Myung Kim
Mar 1, 2019·MSphere·Aimee L BrauerChelsie E Armbruster
Oct 18, 2020·Pathogens·Jordan R GastonChelsie E Armbruster
Aug 28, 2020·International Journal of Medical Informatics·Julie JacquesValérie Leclercq
Jun 1, 2021·ACS Omega·Buddhika GayaniManjula Manoji Weerasekera
Jul 20, 2021·Infection and Immunity·Ashley N WhiteChelsie E Armbruster